MÁ, M., B, C., P, G., & E, M. (2024). Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain. European journal of clinical pharmacology, 80(10), 1503. https://doi.org/10.1007/s00228-024-03706-5
Chicago Style (17th ed.) CitationMÁ, Maciá-Martínez, Castillo-Cano B, García-Poza P, and Martín-Merino E. "Risk of Agranulocytosis with Metamizole in Comparison with Alternative Medications Based on Health Records in Spain." European Journal of Clinical Pharmacology 80, no. 10 (2024): 1503. https://doi.org/10.1007/s00228-024-03706-5.
MLA (9th ed.) CitationMÁ, Maciá-Martínez, et al. "Risk of Agranulocytosis with Metamizole in Comparison with Alternative Medications Based on Health Records in Spain." European Journal of Clinical Pharmacology, vol. 80, no. 10, 2024, p. 1503, https://doi.org/10.1007/s00228-024-03706-5.
